Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease

Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease

US Patent 10324088 · Granted Jun 18, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for assessing mucosal healing in inflammatory bowel disease patients2025
Methods for assessing mucosal healing in inflammatory bowel disease patients2025
Polymeric dyes with linker groups comprising deoxyribose2025
Polymeric tandem dyes with linker groups2025
Polymeric tandem dyes with linker groups2025
Ultra bright dimeric or polymeric dyes with spacing linker groups2025
Method of formulating a pharmaceutical composition comprising administering an i2025
Treatment of a disease of the gastrointestinal tract with a JAK or other kinase 2024
Treatment of a disease of the gastrointestinal tract with an immunosuppressant2024
Programmable polymeric drugs2024
Programmable polymeric drugs2024
Gastrointestinal tract detection methods, devices and systems2024